CRVS- Corvus Pharmaceuticals, Inc.

CRVS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Miller Richard A Md	1.19M	$14.38M	-
CFO	Lea Leiv	400.0K	-	-
Other	Jones William Benton	400.0K	-	-
Other	Arcara Jeffrey	100.0K	-	-
Dir	Chan Andrew C.	30.0K	-	-

Buys and sells only

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jul 25, 2019	Novo Holdings A/s58	10% Owner	Sell	1,492,956	$4.07	$6,077,845.33	-33.8%
Jul 1, 2019	Orbimed Advisors LLC66	Director, 10% Owner	Buy	657,344	$3.72	$2,444,065.11	+11.0%
Jul 1, 2019	Thompson Peter A.63	Director, 10% Owner	Buy	657,344	$3.72	$2,444,065.11	+11.0%
Jun 14, 2019	Miller Richard A Md64	President And CEO	Buy	12,000	$3.41	$40,873.80	+1.0%
Jun 11, 2019	Miller Richard A Md64	President And CEO	Buy	15,212	$3.49	$53,038.65	+1.3%
Jun 7, 2019	Lea Leiv	Chief Financial Officer	Buy	25,500	$3.49	$88,980.00	+103.2%
Dec 27, 2018	Miller Richard A Md64	President And CEO	Buy	20,000	$3.29	$65,884.00	+1.8%
Dec 21, 2018	Lea Leiv	Chief Financial Officer	Buy	24,700	$4.15	$102,408.67	New
Dec 20, 2018	Miller Richard A Md64	President And CEO	Buy	10,000	$4.40	$43,950.00	+0.9%
Dec 6, 2018	Miller Richard A Md64	President And CEO	Buy	5,000	$5.99	$29,934.00	+0.4%